ESElivan Silva Souza

Elivan Silva Souza

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Elivan Silva Souza has a total of 72 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cannabis detection in postmortem toxicology among suicide decedents in the Federal District, Brazil, 2009–2019

    by Amanda Oliveira Lyrio, Elivan Silva Souza, Juliano de Andrade Gomes, Delmason Soares Barbosa de Carvalho, Elaine Ramos de Moraes Rego, Josicélia Estrela Tuy Batista, Sarah dos Santos Conceição, Isaac Suzart Gomes-Filho, Simone Seixas da Cruz, Ana Claudia Morais Godoy Figueiredo, et al.

  • Open Access

    Impactos da Pandemia de COVID-19 nas Atividades de Doação e Transplante de Órgãos: Cenário Global

    by Josélio Emar de Araújo Queiroz, Francisco Álisson Paula de França, Rodrigo Fonseca Lima, Rafael Santos Santana, Elivan Silva Souza, Fernando Antibas Atik, José Osmar Medina de Abreu Pestana, Lídia Einsfeld

    O objetivo deste estudo foi avaliar o impacto da pandemia de COVID-19 no processo de doação e transplante no contexto global. Métodos: Foi realizado um estudo ecológico de 2017 a 2021, examinando o número de doadores e transplantes, bem como os casos e óbitos relacionados à COVID-19. A análise de regressão linear simples foi utilizada em dois blocos: entre 2017 e 2020 e entre 2017 e 2021. Foram consideradas taxas por milhão de habitantes para avaliar os impactos. Resultados: O estudo incluiu 10 países, e Portugal apresentou o impacto mais significativo na taxa de doadores efetivos, com redução de 4.463,8 (intervalo de confiança de 95% [95%CI] -5.103,2–-3.824,4), seguido por Espanha (-3.964,4; 95%CI: -5.850,2–-2.078,6), México (-3.879,3; 95%CI -4.688,6–-3.069,9) e Austrália (-309; 95%CI -565,3–-52,7), ao contrário dos Estados Unidos, que apresentaram aumento. Em termos de taxas de transplante, destacam-se Brasil, Portugal, Espanha, França, Irã e México, que apresentaram redução. Conclusão: A pandemia de COVID-19 causou impactos significativos no processo de doação e transplante em diversos países, e a caracterização desses efeitos é fundamental para a retomada das atividades.

  • Open Access

    Impacts of the COVID-19 Pandemic on Organ Donation and Transplantation Activities: Global Scenario

    by Josélio Emar de Araújo Queiroz, Francisco Álisson Paula de França, Rodrigo Fonseca Lima, Rafael Santos Santana, Elivan Silva Souza, Fernando Antibas Atik, José Osmar Medina de Abreu Pestana, Lídia Einsfeld

    The objective of this study was to assess the impact of the COVID-19 pandemic on the donation and transplant process in the global context. Methods: An ecological study was conducted from 2017 to 2021, examining the numbers of donors and transplants, as well as cases and deaths related to COVID-19. Simple linear regression analysis was used in two blocks: between 2017 and 2020, and between 2017 and 2021. We considered rates per million population to assess the impacts. Results: The study included 10 countries, and Portugal showed the most significant impact on the effective donor rate, with a decrease of 4,463.8 (95% confidence interval [95%CI] -5,103.2–-3,824.4), followed by Spain (-3,964.4; 95%CI -5,850.2–-2,078.6), Mexico (-3,879.3; 95%CI -4,688.6–-3,069.9), and Australia (-309; 95%CI -565.3–-52.7), unlike the United States of America, which showed an increase. In terms of transplant rates, Brazil, Portugal, Spain, France, Iran, and Mexico stood out, also showing decreases. Conclusion: The COVID-19 pandemic had significant impacts on the donation and transplant process in several countries, and characterizing these effects is fundamental to resuming activities.

  • Open Access

    Factors associated with cocaine use among individuals who died by suicide in the Federal District, Brazil

    by Elivan Silva Souza, Amanda Oliveira Lyrio, Juliano de Andrade Gomes, Delmason Soares Barbosa de Carvalho, Elaine Ramos de Moraes Rego, Josicélia Estrela Tuy Batista, Sarah dos Santos Conceição, Isaac Suzart Gomes-Filho, Simone Seixas da Cruz, Ana Claudia Morais Godoy Figueiredo, et al.

    Introduction: Suicide, a leading cause of death among young people and adults, has been increasing worldwide and is closely associated with substance use. Objective: To identify the factors associated with cocaine use in individuals who died by suicide between 2009 and 2019 in the Federal District, Brazil. Methods: This was a cross-sectional study of 1,161 individuals who died by suicide, with data sourced from the Mortality Information System, the Notifiable Diseases Information System (SINAN), and Civil Police records. We estimated crude and age- and sex-adjusted prevalence ratios (PR). Results: The 19–39 age group (PR: 5.2; 95% CI 2.0–13.6), Black or Brown race/skin color (PR: 1.8; 95% CI 1.3–2.5), male sex (PR: 2.9; 95% CI 1.8–4.8), fewer than 8 years of education (PR: 1.5; 95% CI 1.1–1.9), a criminal record (PR: 2.6; 95% CI 1.9–3.5), a history of being a victim of crime (PR: 1.3; 95% CI 1.0–1.8), and a positive toxicology screen for ethanol (PR: 2.9; 95% CI 2.2–3.7) and cannabis (PR: 3.0; 95% CI 2.2–4.0) were among the factors associated with cocaine use. In the adjusted analysis, race/skin color, educational level, criminal record, positive toxicology screens for ethanol and cannabis, and causes of suicide remained associated with the outcome. Conclusion: Social vulnerabilities, a criminal record, and polysubstance use increase the likelihood of cocaine use among individuals who died by suicide. Recognizing these factors can guide targeted interventions and prevention policies aimed at reducing these preventable deaths.


  • Open Access

    Electronic prescription as an instrument for qualifying pharmaceutical assistance in Brazil

    by Josélio Emar Araujo Queiroz, Elivan Silva Souza, Gabriella Nunes Neves, Paula Xavier Santos, Paula Luedy Mendes, Robson Willian Melo Matos, Rafael Santos Santana

    Electronic prescription is a technological innovation that aims to improve the quality of Pharmaceutical Assistance. It allows healthcare professionals to prescribe medications in an electronic record, containing structured and interoperable data, replacing paper prescriptions. This type of prescription brings several benefits to patients, promotes greater patient safety and adherence to treatment, reduces fraud, improves the quality of the medication prescription and dispensing processes and access to information. This study describes the development of the electronic prescription record in the SUS, through the National Health Data Network (RNDS) and its dissemination to patients and health professionals within SUS Digital platforms. As a result, more than 1.8 million records have already been received at RNDS and are therefore available on SUS Digital Profissional platforms. The presentation of such results is another step towards improving patient protagonism, democratizing access and guaranteeing rights, prevention and more effective pharmacotherapeutic monitoring. Electronic prescription is a pharmaceutical assistance qualification instrument, providing greater security, efficiency and control in the medication prescription and dispensing processes. By integrating technology into healthcare, it is possible to improve the quality of care, optimize resources and promote safer and more personalized assistance.

  • Open Access

    Prescrição eletrônica como instrumento de qualificação da assistência farmacêutica no Brasil

    by Joselio Queiroz, Elivan Silva Souza, Gabriella Nunes Neves, Paula Xavier dos Santos, Paula Luedy Mendes, Robson Willian de Melo Matos, Rafael Santos Santana

    A prescrição eletrônica é uma inovação tecnológica que visa aprimorar a qualidade da Assistência Farmacêutica. Permite que profissionais de saúde prescrevam medicamentos em um registro eletrônico, contendo campos e dados estruturados e interoperáveis, substituindo as tradicionais receitas em papel. Essa modalidade de prescrição traz diversos benefícios para a assistência farmacêutica, promovendo a maior segurança de pacientes, redução de fraudes, aprimoramento do fluxo de dados de saúde e da qualidade nos processos de prescrição e dispensação de medicamentos. Este estudo descreve o desenvolvimento do registro de prescrição eletrônica no SUS, por meio da Rede Nacional de Dados em Saúde (RNDS). O modelo informacional de prescrição eletrônica para a RNDS (RPM – Registro de Prescrição de Medicamentos) foi publicado, o desenvolvimento do respectivo modelo computacional e preparação da arquitetura da RNDS para permitir o recebimento das novas mensagens foi finalizado. Como resultado, mais de 4.800 registros já foram recebidos na RNDS e as atividades para apresentação desses dados nas plataformas Conecte SUS estão em andamento. A instituição da prescrição eletrônica na RNDS é mais um passo para aprimorar o protagonismo do cidadão, promover o ambiente de interoperabilidade e fornecimento de informações padronizadas, propiciando ferramentas de monitoramento farmacoterapêutico mais efetivas. A prescrição eletrônica é um instrumento de qualificação da Assistência Farmacêutica, proporcionando maior segurança, eficiência e controle no processo de prescrição e dispensação de medicamentos. Ao integrar a tecnologia aos cuidados de saúde, é possível melhorar a qualidade do atendimento, otimizar recursos e promover uma assistência mais segura e personalizada.

  • Excessive weight in pregnant women increases the chance of diagnosing periodontitis combined with tooth loss

    by Josicélia Estrela Tuy Batista, Ana Claudia Morais Godoy Figueiredo, Elivan Silva Souza, Amanda Oliveira Lyrio, Johelle Santana Passos‐Soares, Soraya Castro Trindade, Claudia Maria Coêlho Alves, Maria Isabel Pereira Vianna, Julita Maria Freitas Coelho, Sarah dos Santos Conceição, et al.

    Background: Excess weight (EW), especially in women of childbearing age, those who are pregnant, as well as postpartum, is a problem worldwide. Fat accumulation deregulates the inflammatory response, contributing to the development of health problems, such as periodontitis. This study investigated the association between EW and periodontitis during pregnancy.Methods: A cross‐sectional, multicenter study involved 1745 postpartum women in Brazil. Socioeconomic‐demographic data, gestational history, lifestyle behavior, and general and oral health conditions were obtained. Pre‐pregnancy body mass index (BMI) was collected from medical records with EW being the exposure. Both tooth loss and clinical attachment level (CAL) were evaluated, and the presence of periodontitis was the outcome. Logistic regression, odds ratio (OR) and 95% confidence interval (95% CI), and quantile regression, beta coefficient and 95% CI, estimated the association between EW (BMI) and periodontitis and its combined effect with tooth loss ≥3, as dichotomous and continuous variables (CAL and tooth loss), with 5% significance level.Results: The EW was 27.7% prevalent and periodontitis was 11.7%. There was a positive association between EW and periodontitis: ORadjusted:1.39; 95% CI:1.01;1.92 and between EW and periodontitis combined with tooth loss ≥3: ORadjusted:1.73; 95% CI:1.36;2.20. The adjusted association between EW and periodontitis as continuous variables was also positive, showing that for each unit of increased BMI, there was an elevation in the mean CAL (p = 0.04) and tooth loss (p < 0.01), with statistical significance.Conclusions: There was a moderate association between EW and periodontitis during pregnancy, with an even greater association of pregnant women with EW presenting periodontitis combined with tooth loss.


  • Open Access

    Certificação de doenças respiratórias agudas na declaração de óbito: um estudo de acurácia

    by Beatriz Alves Souza Borges, Cauê Sousa Cruze Silva, Lourena Bottentuit Cardoso Penha, Luisa Caroline Costa Abreu, Delmason Soares Barbosa de Carvalho, Ana Cristina Machado, Elaine Ramos de Moraes Rego, Amanda Oliveira Lyrio, Sarah dos Santos Conceição, Josicélia Estrela Tuy Batista, et al.

    Resumo Introdução: As doenças respiratórias agudas apresentam difícil mensuração e contribuem para o grande número de causas de óbito mal definidas, o que afeta a confiabilidade das informações de mortalidade. Objetivo: Verificar a acurácia da definição da causa básica de óbito para doenças respiratórias agudas dos óbitos registrados no Sistema de Informações sobre Mortalidade do Distrito Federal em 2018. Método: Foi realizado um estudo de acurácia, com amostra mínima de 331 declarações de óbito com as causas de óbito do capítulo 10 (doenças do aparelho respiratório — J00-J99 — conforme subcategorias) da Classificação Internacional de Doenças na versão 10, considerando a definição de causa básica de óbito pela equipe de investigação como o padrão-ouro. Foram calculadas a sensibilidade, especificidade, valores preditivos positivo e negativo e as razões de verossimilhanças positivas e negativas com os respectivos intervalos de confiança a 95%. Resultados: Total de 396 declarações de óbito foram incluídas. Foi constatada alta sensibilidade para identificar doenças pulmonares agudas nas causas básicas de óbito (82,8%. IC95% 78,6–86,5) e alta especificidade (93,1%. IC95% 77,2–99,2). A probabilidade de a declaração apresentar resultado falso negativo foi baixa (0,2. IC95% 0,1–0,2). Conclusão: As declarações de óbito por doenças respiratórias agudas apresentaram bons resultados para acurácia e incitam a realização de estudos semelhantes para outras condições.

  • Open Access

    The Brazilian international patient summary initiative

    by Beatriz de Faria Leao, Italo Macedo Do Amaral Costa, Joice Machado, Monalisa de Assis Molla, Aline Rodrigues Zamarro, Fabiane Raquel Motter, Gabriel Gausmann Oliveira, Karla L de A Calvette Costa, Blanda Helena de Mello, Elivan Silva Souza, et al.

    This paper describes the development of the Brazilian version of the International Patient Summary (IPS). A joint technical team is developing the project from Syrian-Lebanese Hospital, São Paulo, and the Coordination of Innovation and Informatics in Health, Secretariat of Information and Digital Health, Brazilian Ministry of Health. The five-phased approach used in the development of Brazil IPS starts with the identification of the Brazilian Ministry of Health national terminologies used to represent concepts for problems, diagnosis and procedures, their upload in a terminology server and mapping to IPS ValueSets, the Fast Healthcare Interoperability Resources profiles customization and, finally, the complete Brazil IPS Implementation Guide is described.


  • Open Access

    Temporal Trends in Mortality from Alzheimer’s Disease in Federal District, Brazil: An Ecological Study (2010–2018)

    by Sarah dos Santos Conceição, Delmason Soares Barbosa de Carvalho, Josicélia Estrela Tuy Batista, Amanda Oliveira Lyrio, Elivan Silva Souza, Paulo José dos Santos de Matos, Alexandre Marcelo Hintz, Simone Seixas da Cruz, Isaac Suzart Gomes-Filho, Ana Claudia Morais Godoy Figueiredo

    Introduction: Neuropsychiatric diseases, particularly dementias, has become more prominent with a great impact on the quality of life of the elderly population. Objective: To verify the rate of increase in mortality due to Alzheimer’s disease in the Federal District, Brazil from 2010 to 2018. Method: An ecological study was conducted, with a time series, about the evolution of the mortality coefficient in the Federal District, Brazil carried out at the Federal District State Department of Health. Mortality rates were defined as the dependent variable and years evaluated as the independent variable—from 2010 to 2018. For temporal trend analysis, the Prais–Winsten linear regression model was used and the increment rate with the respective 95% confidence interval was estimated. Results: From 2010 to 2018, 1665 deaths which had Alzheimer’s disease as the underlying cause were recorded in the Mortality Information System. The results showed an overall mortality rate of 6.55 deaths per 100,000 inhabitants, with a higher predominance in females, non-Black people, and those aged 80 years or older. There was an increase in the annual trend of the overall mortality coefficient in both sexes. Conclusion: The findings demonstrated a significant increase in the temporal evolution of mortality due to Alzheimer’s disease in the Federal District, Brazil. It was recommended to conduct original studies to evaluate the factors that can cause the disease in order to collaborate in the process of formulating policies in the area of public health and improvements in clinical practice.